Figures
Abstract
Paternal age has been associated with offspring congenital heart defects (CHDs), which might be caused by increased mutations in the germ cell line because of cumulated cell replications. Empirical evidences, however, remain inconclusive. Furthermore, it is unknown whether all subtypes of CHDs are affected by paternal age. We aimed to explore the relationship between paternal age and the risk of offspring CHDs and its five common subtypes using national register data in Denmark. A total of 1 893 899 singletons born in Denmark from 1977 to 2008 were included in this national-based cohort study. Cox’s proportion hazards model with robust sandwich estimate option was used to estimate the hazards ratio (95% confidence interval) for the associations between paternal age and all CHDs, as well as subtypes of CHDs (patent ductus arteriosus (PDA), ventricular septal defect (VSD), atrial septal defect (ASD), tetralogy of fallot (TOF) and coarctation of the aorta (CoA)). We did not observe an overall association between paternal age and offspring CHDs. However, compared to the paternal age of 25–29 years, paternal age of older than 45 years was associated with a 69% increased risk of PDA (HR45+ = 1.69, 95%CI:1.17–2.43). We observed similar results when subanalyses were restricted to children born to mothers of 27–30 years old. After taking into consideration of maternal age, our data suggested that advanced paternal age was associated with an increased prevalence of one subtype of offspring congenital heart defects (CHDs), namely patent ductus arteriosus (PDA).
Citation: Su XJ, Yuan W, Huang GY, Olsen J, Li J (2015) Paternal Age and Offspring Congenital Heart Defects: A National Cohort Study. PLoS ONE 10(3): e0121030. https://doi.org/10.1371/journal.pone.0121030
Academic Editor: Zoha Kibar, CHU Sainte Justine and University of Montreal, CANADA
Received: July 16, 2014; Accepted: February 8, 2015; Published: March 25, 2015
Copyright: © 2015 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: The authors confirm that, for approved reasons, some access restrictions apply to the data underlying the findings. Access to data should apply permissions to Danish National Data protection Agency and Denmark Statistics.
Funding: The study was supported by the European Research Council (ERC-2010-StG-260242-PROGEURO), the Danish Medical Research Council (project no. 09-072986), the National Basic Research Program of China (973 program), 2010 CB 529504. XJS is partly supported by a travel grant from Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine and Youth Foundation of Shanghai Municipal Commission of Health and Family Planning (20124y176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Congenital heart defects (CHDs) are the most common congenital malformations, affecting 5–10 per 1000 live births [1–3] but the etiology of CHDs remains to be identified. Advanced parental age, race, ethnicity, and chemical agents have been proposed as potential risk factors [4–6]. It was also reported that there is gender difference in the prevalence of CHDs [7]. Postponement of maternal age for first child birth could be observed in many countries since 1970s [8]. Similar to maternal age, there has been a 20% increase for children born to fathers over 35 years old in the past 20 years in USA, and the paternal childbearing peak years has changed from 25–29 years to 30–34 years since 2008 [9]. The average paternal age at child birth has also exceeded 40 years old and more than 40% of fathers were 40–49 years old at child birth in 2006 in Canada [10].
It has been speculated that paternal age was critically significant for gene mutation since 1955 [11], and it was reported the diversity in mutation rates of single nucleotide polymorphisms is dominated by paternal age at conception of the child by sequencing the entire genomes of 78 Icelandic parent–offspring trios at high coverage [12]. Some behavior factors may interact with genetic factors related to the paternal age on the development of offspring, such as smoking and alcohol etc. [13,14]. Paternal age has been related to an increased prevalence of different types of birth defects, such as abnormal limbs and neural tube defects [15,16]. Recently, advanced paternal age is proposed to be a risk factor of the heart malformation in the offspring in some studies [17–20], but not in the others [21–23]. Two studies have examined the subtypes of CHDs with inconsistent findings. Olshan et al observed increased risks of ventricular septal defect (VSD) and atrial septal defect (ASD) in children born to fathers younger than 20 years old or older than 35 years old, while an increased risk of patent ductus arteriosus (PDA) was found in children born to fathers older than 35 years old [18]. Bassili et al reported that paternal age of older than 40 years was a risk factor for VSD, but not for ASD [24]. Due to the close correlation between paternal age and maternal age, it may be misleading to examine the effects of paternal age without taking maternal age into consideration.
Considering high prevalence of CHDs and limited epidemiological evidences related to paternal age effect on specific types of CHDs, we conducted this national-based cohort study to explore the association between paternal age and overall risk of CHDs in the offspring, including the five major subtypes of CHDs.
Materials and Methods
The population-based cohort study was based on secondary data and all analyses were done at the secure platform of Denmark Statistics, using encrypted identification numbers without any access to personal identification numbers. The study was approved by the Danish Data Protection Agency (J NR. 2008–41–2680) and the local ethics committee in Central Denmark Region (VEK, case number M-201000252).
Every live birth was assigned a unique personal civil registration number, which can be used to link the information at individual level among all national registries. Data was retrieved from several Danish registries, including the Danish Medical Birth Registry [25], the Danish Register of Congenital Heart Disease [26], the Danish National Patient Register [27], and the Danish Civil Registration System [28].
Study population
We identified 1 927 278 liveborn singletons in Denmark between January 1, 1977 and December 31, 2008 from the Danish Medical Birth Registry. We excluded 33 379 (1.73%) children with no information on the mother and the father. A total of 1 893 899 singletons remained in the study.
Exposure and outcome
We used the Danish Civil Registration System to identify the paternal and maternal birth date, and then calculated their ages at the time of delivery [28]. The paternal age was treated as continuous variable and also categorized into seven groups (<20, 20–24, 25–29, 30–34, 35–39, 40–44, 45+ years).
CHDs were obtained from the Danish Register of Congenital Heart Disease, which contains data on CHDs from 1963 to the present [26]. Diseases were coded by the 8th Revision of the International Classification of Diseases (ICD-8) until the end of 1993 and thereafter the 10th Revision(ICD-10) [27]. ICD-8 codes for CHDs were 746–747, except for 746.7, 746.9 and 747.5–747.9; and ICD-10 codes for CHDs were Q20-Q26, except for Q20.9, Q21.9, Q24.9, Q25.9, Q26.5, Q26.6 and Q26.9 [29]. Children with more than one type of CHDs were categorized according to first CHDs diagnosis in the registry.
The most five common CHDs included patent ductus arteriosus (PDA, codes 747.0(ICD-8) and Q25.0 (ICD-10)), ventricular septal defect (VSD, codes 746.3 (ICD-8) and Q21.0 (ICD-10)), atrial septal defect (ASD, codes 746.4 (ICD-8) and Q21.1 (ICD-10)), tetralogy of fallot (TOF, codes 746.2 (ICD-8) and Q21.3 (ICD-10)) and coarctation of the aorta (CoA, codes 747.1 (ICD-8) and Q25.1 (ICD-10)).
Statistical analysis and potential confounders
The statistical software package SAS version 9.2 (SAS Institute Inc., Cary, NC, USA) was used for data analysis. CHDs are malformations present at birth but often identified later on life, therefore the length of follow-up has to be taken into consideration. Cox’s proportion hazards model was used to estimate hazards ratios (HRs) and corresponding 95% confidence interval (95%CI). Follow up start from the birth date of the children, ended on the date of CHDs diagnosis, death, emigration, or the end of follow up on December 31, 2010, whichever came first. We observed that the hazards of offspring CHDs for different paternal age groups are proportional over time (S1 Fig.). The robust sandwich estimate option was used to deal with the potential cluster effect caused by siblings.
The age group of 25–29 years was treated as the reference group because it might be expected to be the optimal childbearing age period [30,31]. Since maternal age was non-linear associated with CHDs [32], it was included in the model both linear and quadratic terms in 1 year unit to secure a better fit of the model [33]. Considering different parental age pattern might bias the correlation between paternal age and prevalence of CHDs [34], the absolute value of parental age difference was also included in the model (<5, 5–9, ≥10 years). Genetic factor was proposed be a risk factor of CHDs. Family history of CHDs as a consequence was included in the model, identified by the fact that one of close relatives was diagnosed as CHDs, including father, mother, sibling, grandmother and grandfather by the Danish Register of Congenital Heart Disease. Because of its effect on the fetus development [35], maternal infection during pregnancy was also included in the model identified by the Danish National Patient Register. For the overall prevalence of CHDs, the analysis was carried out in two models. In the first model, linear and quadratic terms of maternal age, parental age difference (<5, 5–9, ≥10 years), gender of the children (girl, boy), parity (1st, 2nd, 3rd and higher), calendar year of the children (1977–1980, 1981–1985, 1986–1990, 1991–1995, 1996–2000, 2001–2005, 2006–2008) were included (Model 1). In the second model, in addition to those covariates in model 1, family history of CHDs and maternal infection during pregnancy were further added (Model 2). Only model 2 was used to estimate adjusted HRs regarding to subtypes of CHDs.
Maternal age was closely correlated with paternal age (r = 0.68 in this data set). Thus we performed subanalyses to estimate the HRs of CHDs and its subtypes by restricting to children with 27–30 years of maternal age (n = 590 455), which could reduce the confounding by maternal age effect. In order to avoid potential sparse data bias, the paternal age was re-categorized into 5 groups by combining the <20 years group and 20–24 years group into one group (≤24 years), so was the 40–44 years group and 45+ years group (40+ years). We performed sensitivity analyses among children without (n = 1 849 348) or with CHDs family history (n = 44 551) to partly disentangle genetic effects from paternal age effects. Because data on the maternal social status and maternal smoking was available after 1981 and 1991 respectively, we conducted subanalyses among children born after 1981 adjusted for the covariates in model 2, and additionally for maternal social status at birth (not in the labor, blue collar, white collar, higher position, missing) (Model 3). Then we performed subanalyses among children born after 1991 adjusted for the covariates in model 3, and additionally for maternal smoking status (yes, no) (Model 4). We also did stratified analyses by child’s gender to explore the gender difference as reported in previous studies [7].
Results
Table 1 shows the sociodemographic characteristics among different paternal age groups. About 63.69% children were born to fathers at 25–34 years of age at birth. Children born to older fathers were likely to have older mothers. The proportion of maternal infection during pregnancy was higher both in younger and advanced paternal age group. Children born to younger fathers were more likely to have smoking mothers who were also not in the labor market.
A total of 15 216 (0.80%) CHDs were ascertained from 1 893 899 live births. Compared to the reference group, there was no difference in the prevalence of overall CHDs in different paternal age groups by model 1 and model 2 (Table 2). The results for each subtype of CHDs are shown in S1 Table. We observed paternal age of older than 45 years of age had an increasing risk of PDA in the offspring (HR45+ = 1.69, 95%CI: 1.17–2.43) (Table 3). No statistically significant associations were observed between paternal age and prevalence of ASD, VSD, TOF, and CoA.
The sub-analyses results restricted to children born to mothers of 27–30 years were shown in Table 4. Children born to fathers older than 40 years had an increasing prevalence of PDA (HR40+ = 1.60, 95%CI: 1.10–2.32). We found similar results when we restricted analyses to children without CHDs family history (S2 Table). When analyses were restricted to children with CHDs family history, we observed increased risks for both overall and subtypes of CHDs (S3 Table). Similar to the main analyses, we only observed an increasing risk of PDA for paternal age of older than 45 years of age when analyses were restricted to children born after 1981 by model 3 (data not shown). However, the HR of PDA tended to be insignificant when restricting children born after 1991 by model 4 (HR45+ = 1.33, 95%CI: 0.95–1.84) (data not shown). We did not find the gender difference of the associations between paternal age and CHDs (data not shown).
Discussion
In this study, we did not find an overall association between paternal age and prevalence of offspring’s combined CHDs. No associations were observed between paternal age and prevalences of ASD, VSD, TOF and CoA in the offspring. However, we observed an increased prevalence of PDA associated with paternal age of older than 45 years.
The biological mechanism behind the association between paternal age and offspring CHDs is not clear but several hypotheses have been proposed. First, increasing male age is associated with a deterioration of semen quality, including volume, sperm concentration, motility and morphology [36]. Second, there are increasing mutations as increasing germ cell replications error following the advanced paternal age [37]. In addition, older males have increased sperm DNA damages associated with alkali-labile sites or single-strand DNA breaks. DNA damages in sperm can be converted to chromosomal aberrations and gene mutations after fertilization, increasing the risk of the developmental defects and genetic diseases among offspring [38]. Third, exposure to environmental risk factors may be linked to sperm genetic change because of accumulated effects. This was elaborated both in animal models and the epidemiologic studies [39,40]. Forth, the present explanation for the young paternal age effect is that more unhealthy lifestyle among young couples may be prevalent, such as smoking and alcohol use [16].
However, our findings on no overall association between paternal age and prevalence of CHDs, which are consistent with some previous studies [41,42], but not the others [17,20,24]. One reason could be that maternal age was not well taken into consideration in previous studies. We observed that children born to younger fathers were more likely to have mothers with smoking habits, infections in pregnancy and not in the labor market. Similar to our study, young paternal age was observed to be associated with CHDs found in a Norwegian study, and this could be attributable to unhealthy life styles, as suggested by the authors [16]. In addition, the Danish Register of Congenital Heart Disease, which is used to identify the cases in the present study, has excluded children diagnosed with isolated ASD, VSD or PDA before the age of 2 months if there were no subsequent records of CHDs in the DNPR [43], which could attenuate the overall association.
There has been very limited research on the association between paternal age and subtypes of CHDs [18,23,24]. Mutations in three transcription factor genes, TBX5, NKX2–5 and GATA4 have been reported, which can induce secundum ASDs and mutation in CRELD1, encoding a cell adhesion molecule causing AVSDs [44]. It has been suggested that mutation TFAP2B causes Char syndrome, which is a familial form of PDA [45]. All these studies indicate that different underlying biological mechanisms among different subtypes of CHDs. However, there has been no research on the association between these gene mutations and paternal age. We found advanced paternal age was associated with increasing prevalence of the PDA. This was consistent with a previous study in which the authors found increasing prevalence of PDA with increasing paternal ages [18]. We did not find an association between paternal age and prevalence of the other four subtypes of CHDs, which is partly supported by three previous studies [23,24,46]. In addition, when restricted analyses to children born to mother with 27–30 years of age, we found an increased prevalence of TOF and CoA among children with advanced paternal age, as well an increased prevalence of PDA, VSD and CoA among children with younger paternal age. However, all of these associations were statistically insignificant, which might be due to small sample size.
To the best of our knowledge, the present study has the largest sample size based on national population data, which allowed us to evaluate the independent effect of paternal age on subtypes of CHDs by taking the effect of maternal age into consideration. However, our findings should be interpreted with caution in the light of following limitations: (1) we do not have data on paternal lifestyle factors. (2) Because of lacking of standard transformation between the ICD-8 and ICD-10, we could not analyze more subtypes of CHDs during this period. (3) We have data on live births only, not data on the stillbirth, spontaneous abortion, and other pregnancy terminations, which, however, might lead to underestimations of the associations between paternal age and offspring CHDs.
To conclude, after taking into consideration of maternal age and other potential confounders, we observed that there was no association between paternal age and prevalence of offspring overall CHDs. However, our data suggested that advanced paternal age may be associated with an increased prevalence of a subtype of CHDs, namely PDA.
Supporting Information
S1 Fig. Test the assumption of Cox’s proportional hazards model.
Hazards in different paternal age groups compared with reference age group (25–29 years) are almost proportional over time.
https://doi.org/10.1371/journal.pone.0121030.s001
(TIF)
S1 Table. Incidence Rate of subtypes of CHDs in different paternal age groups.
https://doi.org/10.1371/journal.pone.0121030.s002
(DOCX)
S2 Table. Adjusted hazards ratio of CHDs and its five common subtypes among children without CHDs family history by different paternal age groups.
https://doi.org/10.1371/journal.pone.0121030.s003
(DOCX)
S3 Table. Adjusted hazards ratio of CHDs and its five common subtypes among children with CHDs family history by different paternal age groups.
https://doi.org/10.1371/journal.pone.0121030.s004
(DOCX)
Author Contributions
Conceived and designed the experiments: XJS WY GYH JO JL. Performed the experiments: XJS JL. Analyzed the data: XJS. Wrote the paper: XJS WY GYH JO JL.
References
- 1. Bjornard K, Riehle-Colarusso T, Gilboa SM, Correa A. Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol. 2013;97: 87–94. pmid:23404870
- 2. Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. National time trends in congenital heart defects, Denmark, 1977–2005. Am Heart J. 2009;157: 467–473 e461. pmid:19249416
- 3. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998–2005. J Pediatr. 2008;153: 807–813. pmid:18657826
- 4. Miller A, Riehle-Colarusso T, Siffel C, Frias JL, Correa A. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A. 2011;155A: 2137–2145. pmid:21815253
- 5. Nembhard WN, Wang T, Loscalzo ML, Salemi JL. Variation in the prevalence of congenital heart defects by maternal race/ethnicity and infant sex. J Pediatr. 2010;156: 259–264. pmid:19818453
- 6. Snijder CA, Vlot IJ, Burdorf A, Obermann-Borst SA, Helbing WA, Wildhagen MF, et al. Congenital heart defects and parental occupational exposure to chemicals. Hum Reprod. 2012;27: 1510–1517. pmid:22357765
- 7. Samanek M. Boy:girl ratio in children born with different forms of cardiac malformation: a population-based study. Pediatr Cardiol. 1994;15: 53–57. pmid:7997413
- 8.
OECD. OECD Family Database. OECD, Paris; 2014.
- 9.
Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Matthews T. Births: final data for 2011. National Vital Statistics Report 62; 2013.
- 10.
Canada S. Statistics Canada, General Social Survey, 1995 and 2006. Statistics Canada; 2010.
- 11. Penrose LS. Parental age and mutation. Lancet. 1995;269: 312–313.
- 12. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, et al. Rate of de novo mutations and the importance of father's age to disease risk. Nature. 2012;488: 471–475. pmid:22914163
- 13. Savitz DA, Schwingl PJ, Keels MA. Influence of paternal age, smoking, and alcohol consumption on congenital anomalies. Teratology. 1991;44: 429–440. pmid:1962288
- 14. Mutsaerts MA, Groen H, Huiting HG, Kuchenbecker WK, Sauer PJ, Land JA, et al. The influence of maternal and paternal factors on time to pregnancy—a Dutch population-based birth-cohort study: the GECKO Drenthe study. Hum Reprod. 2012;27: 583–593. pmid:22184203
- 15. Grewal J, Carmichael SL, Yang W, Shaw GM. Paternal age and congenital malformations in offspring in California, 1989–2002. Matern Child Health J. 2012;16: 385–392. pmid:21344170
- 16. Kazaura M, Lie RT, Skjaerven R. Paternal age and the risk of birth defects in Norway. Ann Epidemiol. 2004;14: 566–570. pmid:15350956
- 17. Materna-Kiryluk A, Wisniewska K, Badura-Stronka M, Mejnartowicz J, Wieckowska B, Balcar-Boron A, et al. Parental age as a risk factor for isolated congenital malformations in a Polish population. Paediatr Perinat Epidemiol. 2009;23: 29–40. pmid:19228312
- 18. Olshan AF, Schnitzer PG, Baird PA. Paternal age and the risk of congenital heart defects. Teratology. 1994;50: 80–84. pmid:7974258
- 19. Baltaxe E, Zarante I. Prevalence of congenital heart disease in 44,985 newborns in Colombia. Arch Cardiol Mex. 2006;76: 263–268. pmid:17091797
- 20. Yang Q, Wen SW, Leader A, Chen XK, Lipson J, Walker M. Paternal age and birth defects: how strong is the association? Hum Reprod. 2007;22: 696–701. pmid:17164268
- 21. Cedergren MI, Selbing AJ, Kallen BA. Risk factors for cardiovascular malformation—a study based on prospectively collected data. Scand J Work Environ Health. 2002;28: 12–17. pmid:11873776
- 22. Zhan SY, Lian ZH, Zheng DZ, Gao L. Effect of fathers' age and birth order on occurrence of congenital heart disease. J Epidemiol Community Health. 1991;45: 299–301. pmid:1795151
- 23. Ewing CK, Loffredo CA, Beaty TH. Paternal risk factors for isolated membranous ventricular septal defects. Am J Med Genet. 1997;71: 42–46. pmid:9215767
- 24. Bassili A, Mokhtar SA, Dabous NI, Zaher SR, Mokhtar MM, Zaki A. Risk factors for congenital heart diseases in Alexandria, Egypt. Eur J Epidemiol. 2000;16: 805–814. pmid:11297222
- 25. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45: 320–323. pmid:9675544
- 26. Olsen M, Videbaek J, Johnsen SP. Danish Register of Congenital Heart D. The Danish Register of Congenital Heart Disease. Scand J Public Health. 2011;39: 50–53. pmid:21898918
- 27. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39: 30–33. pmid:21775347
- 28. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39: 22–25. pmid:21775345
- 29. Olsen M, Videbaek J, Johnsen SP, Danish RoCHD. The Danish Register of Congenital Heart Disease. Scand J Public Health. 2011;39: 50–53. pmid:21898918
- 30. Alio AP, Salihu HM, McIntosh C, August EM, Weldeselasse H, Sanchez E, et al. The effect of paternal age on fetal birth outcomes. Am J Mens Health. 2012;6: 427–435. pmid:22564913
- 31. Jaleel R, Khan A. Paternal factors in spontaneous first trimester miscarriage. Pak J Med Sci. 2013;29: 748–752. pmid:24353621
- 32. Croen LA, Shaw GM. Young Maternal Age and Congenital-Malformations—a Population-Based Study. American Journal of Public Health. 1995;85: 710–713. pmid:7733434
- 33.
McDonald JH. polynomial regression. Handbook of Biological Statistics: Sparking house. 2008;pp. 205–210.
- 34. Green RF, Devine O, Crider KS, Olney RS, Archer N, Olshan AF, et al. Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol. 2010;20: 241–249. pmid:20056435
- 35. Botto LD, Panichello JD, Browne ML, Krikov S, Feldkamp ML, Lammer E, et al. Congenital heart defects after maternal fever. Am J Obstet Gynecol. 2014;210: 359 e351–359 e311. pmid:24184180
- 36. Das M, Al-Hathal N, San-Gabriel M, Phillips S, Kadoch IJ, Bissonnette F, et al. High prevalence of isolated sperm DNA damage in infertile men with advanced paternal age. J Assist Reprod Genet.2013;30: 843–848. pmid:23722935
- 37. Goriely A, Wilkie AO. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet. 2012;90: 175–200. pmid:22325359
- 38. Schmid TE, Eskenazi B, Baumgartner A, Marchetti F, Young S, Weldon R, et al. The effects of male age on sperm DNA damage in healthy non-smokers. Hum Reprod. 2007;22: 180–187. pmid:17053003
- 39. Jafarabadi M. Episodic air pollution is associated with increased DNA fragmentation in human sperm without other changes in semen quality. Hum Reprod. 2007;22: 3263. pmid:17947377
- 40. Farag AT, Radwan AH, Sorour F, El Okazy A, El-Agamy el S, El-Sebae Ael K. Chlorpyrifos induced reproductive toxicity in male mice. Reprod Toxicol. 2010;29: 80–85. pmid:19850121
- 41. Tay JS, Yip WC, Joseph R. Parental age and birth order in Chinese children with congenital heart disease. J Med Genet. 1982;19: 441–443. pmid:7154041
- 42. Zhu JL, Madsen KM, Vestergaard M, Olesen AV, Basso O, Olsen J. Paternal age and congenital malformations. Hum Reprod. 2005;20: 3173–3177. pmid:16006461
- 43. Jepsena B, Jepsena P, Johnsena SP, Espersenb GT, Sørensena HT. Validity of diagnoses of cardiac malformations in a Danish population-based hospital-discharge registry. International Journal of Risk & Safety in Medicine. 2006;18: 77–81.
- 44. Gelb BD. Genetic basis of congenital heart disease. Curr Opin Cardiol. 2004;19: 110–115. pmid:15075735
- 45. Satoda M, Zhao F, Diaz GA, Burn J, Goodship J, Davidson HR, et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet. 2000;25: 42–46. pmid:10802654
- 46. Du ZD, Roguin N, Barak M, Bihari SG, Ben-Elisha M. High prevalence of muscular ventricular septal defect in preterm neonates. Am J Cardiol. 1996;78: 1183–1185. pmid:8914891